Company: SXTPW
Filing Date: 2025-01-28
Form Type: 8-K
Source: 0001213900-25-007529
Chunk: 1

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-28
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The following exhibits are being filed herewith:

  Exhibit      Description                                            
      No.                                                             
     99.1      Press Release dated January 28, 2025                   
 ──────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the  

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

                              60 DEGREES PHARMACEUTICALS, INC.                                             
  Date: January 28, 2025      By:                                   /s/ Geoffrey Dow                       
                              Name:                                 Geoffrey Dow                           
                              Title:                                Chief Executive Officer and President